Published in N Engl J Med on January 17, 2008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA (2010) 13.88
Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data. Lancet (2012) 9.43
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med (2009) 6.89
Evidence based medicine: a movement in crisis? BMJ (2014) 6.78
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ (2012) 6.39
A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47
Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med (2010) 5.18
Why current publication practices may distort science. PLoS Med (2008) 5.09
Non-publication of large randomized clinical trials: cross sectional analysis. BMJ (2013) 4.91
Increasing value and reducing waste: addressing inaccessible research. Lancet (2014) 4.83
Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review. PLoS One (2013) 4.38
Medicine. Moving toward transparency of clinical trials. Science (2008) 4.36
Compliance with results reporting at ClinicalTrials.gov. N Engl J Med (2015) 4.17
Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol (2009) 3.99
How frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database. PLoS One (2014) 3.87
Commentary: practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology. Oncologist (2008) 3.71
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65
Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med (2008) 3.64
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med (2008) 3.57
Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ (2013) 3.51
Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ (2011) 3.50
The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication. Dtsch Arztebl Int (2010) 3.36
Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry (2012) 3.29
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ (2010) 2.88
Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results. PLoS Med (2015) 2.84
Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin. PLoS Med (2013) 2.82
Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers. Nat Rev Drug Discov (2010) 2.63
Bias, spin, and misreporting: time for full access to trial protocols and results. PLoS Med (2008) 2.60
Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols. BMJ (2008) 2.56
Packages of care for depression in low- and middle-income countries. PLoS Med (2009) 2.50
Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry (2009) 2.49
Reporting bias in medical research - a narrative review. Trials (2010) 2.44
Why we need easy access to all data from all clinical trials and how to accomplish it. Trials (2011) 2.25
Are psychiatrists an endangered species? Observations on internal and external challenges to the profession. World Psychiatry (2010) 2.24
The importance of clinical trial data sharing: toward more open science. Circ Cardiovasc Qual Outcomes (2012) 2.16
Reporting of results in ClinicalTrials.gov and high-impact journals. JAMA (2014) 2.10
Teaching trainees to negotiate research collaborations with industry: a mentorship model. Am J Psychiatry (2010) 2.04
[Antidepressants for treatment of depression in palliative patients : a systematic literature review]. Schmerz (2012) 2.04
Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med Res Methodol (2009) 2.01
How large are the nonspecific effects of acupuncture? A meta-analysis of randomized controlled trials. BMC Med (2010) 2.00
Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy. PLoS One (2011) 1.98
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry (2013) 1.92
Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care (2010) 1.82
The genetics of major depression. Neuron (2014) 1.80
Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand (2008) 1.78
Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med (2013) 1.78
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies. BMJ (2014) 1.72
Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. Trends Cogn Sci (2014) 1.69
Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis. BMJ (2014) 1.67
Efficacy of peer support interventions for depression: a meta-analysis. Gen Hosp Psychiatry (2010) 1.63
The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J Psychosom Res (2011) 1.63
Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry (2009) 1.63
Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database. PLoS Med (2012) 1.62
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philos Ethics Humanit Med (2008) 1.61
Is there an excess of significant findings in published studies of psychotherapy for depression? Psychol Med (2014) 1.60
Dishonesty in medicine revisited. Tex Heart Inst J (2008) 1.59
A systematic review of comparative efficacy of treatments and controls for depression. PLoS One (2012) 1.57
Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol (2012) 1.56
Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials. PLoS Med (2014) 1.55
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder. Am J Psychiatry (2015) 1.55
Mandatory disclosure of trial results for drugs and devices. BMJ (2008) 1.55
Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO. J R Soc Med (2011) 1.53
The proposed rule for U.S. clinical trial registration and results submission. N Engl J Med (2014) 1.51
Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies. BMC Med Res Methodol (2009) 1.51
Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports. BMJ Open (2013) 1.48
Publication bias and the limited strength model of self-control: has the evidence for ego depletion been overestimated? Front Psychol (2014) 1.48
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants. BMC Med (2012) 1.46
Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health (2011) 1.46
Rethinking recommendations for screening for depression in primary care. CMAJ (2011) 1.46
Mobile, Social, and Wearable Computing and the Evolution of Psychological Practice. Prof Psychol Res Pr (2012) 1.43
Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med (2009) 1.43
Unlocking Health Canada's cache of trade secrets: mandatory disclosure of clinical trial results. CMAJ (2011) 1.43
More depressing news on antidepressants: should we panic? Psychiatry (Edgmont) (2008) 1.39
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry (2017) 1.39
An end to depression in primary care? Br J Gen Pract (2012) 1.38
Should we screen for emotional distress in type 2 diabetes mellitus? Nat Rev Endocrinol (2009) 1.37
Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med (2013) 1.35
Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis. PLoS One (2009) 1.33
Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? Br J Clin Pharmacol (2008) 1.33
Issues in noninferiority trials: the evidence in community-acquired pneumonia. Clin Infect Dis (2008) 1.32
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer (2009) 1.31
Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials. CMAJ (2008) 1.28
Declaration of transparency for each research article. BMJ (2013) 1.27
Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up. Contemp Clin Trials (2010) 1.26
Estimating the number needed to treat from continuous outcomes in randomised controlled trials: methodological challenges and worked example using data from the UK Back Pain Exercise and Manipulation (BEAM) trial. BMC Med Res Methodol (2009) 1.26
Antidepressants normalize the default mode network in patients with dysthymia. JAMA Psychiatry (2013) 1.25
Academia and the company coin. Nat Biotechnol (2009) 1.24
Publication bias in laboratory animal research: a survey on magnitude, drivers, consequences and potential solutions. PLoS One (2012) 1.23
Efficacy of antidepressants. BMJ (2008) 1.23
The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration. PLoS One (2014) 1.22
Policy forum: studying eyewitness investigations in the field. Law Hum Behav (2007) 2.70
Surgeons' tone of voice: a clue to malpractice history. Surgery (2002) 2.18
Small conductance Ca2+-activated K+ channels modulate synaptic plasticity and memory encoding. J Neurosci (2002) 2.03
Physical therapists' nonverbal communication predicts geriatric patients' health outcomes. Psychol Aging (2002) 1.38
Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med (2013) 1.35
Physician and patient communication training in primary care: effects on participation and satisfaction. Health Psychol (2008) 1.26
Efficacy of antidepressants. BMJ (2008) 1.23
Quantifying construct validity: two simple measures. J Pers Soc Psychol (2003) 1.21
Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs (2006) 1.20
Cognitive issues in fingerprint analysis: inter- and intra-expert consistency and the effect of a 'target' comparison. Forensic Sci Int (2010) 1.11
Science and ethics in conducting, analyzing, and reporting psychological research. Psychol Sci (1994) 0.97
Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review. J Clin Psychiatry (2008) 0.95
Meta-analytically quantifying the reliability and biasability of forensic experts. J Forensic Sci (2008) 0.91
Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study. J Vet Intern Med (2007) 0.90
Repeated-measures contrasts for "multiple-pattern" hypotheses. Psychol Methods (2003) 0.85
Improving construct validity: Cronbach, Meehl, and Neurath's ship. Psychol Assess (2005) 0.83
Contrasts and correlations in theory assessment. J Pediatr Psychol (2001) 0.81
Using the QIDS-SR16 to identify major depressive disorder in primary care medical patients. Behav Ther (2010) 0.81
Detecting state and trait anxiety from auditory and visual cues: a meta-analysis. Pers Soc Psychol Bull (2004) 0.77
Lineup administrator influences on eyewitness identification decisions. J Exp Psychol Appl (2009) 0.77
Improving reporting of clinical trials in veterinary medicine. J Vet Intern Med (2010) 0.76
Tobacco control in VA hospitals. JAMA (2009) 0.75
Editorial on "Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders". Gen Hosp Psychiatry (2008) 0.75
Lamotrigine-associated Stevens-Johnson syndrome after discontinuation of interferon, ribavirin, and filgrastim: a case report. J Clin Psychiatry (2007) 0.75